Siddiqi TJ, Khan MS, Fonarow GC, Butler J, et al. Reply to commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular kidney-metabolic comorbidity'. Eur J Heart Fail 2026 Jan 8:xuaf004. doi: 10.1093.
PMID: 41771103